5,308 reports of this reaction
15.0% of all ABEMACICLIB reports
#1 most reported adverse reaction
DIARRHOEA is the #1 most commonly reported adverse reaction for ABEMACICLIB, manufactured by Eli Lilly and Company. There are 5,308 FDA adverse event reports linking ABEMACICLIB to DIARRHOEA. This represents approximately 15.0% of all 35,479 adverse event reports for this drug.
Patients taking ABEMACICLIB who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIARRHOEA is a frequently reported adverse event for ABEMACICLIB, accounting for a significant proportion of all reports.
In addition to diarrhoea, the following adverse reactions have been reported for ABEMACICLIB:
The following drugs have also been linked to diarrhoea in FDA adverse event reports:
DIARRHOEA has been reported as an adverse event in 5,308 FDA reports for ABEMACICLIB. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIARRHOEA accounts for approximately 15.0% of all adverse event reports for ABEMACICLIB, making it one of the most commonly reported side effect.
If you experience diarrhoea while taking ABEMACICLIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.